Grupo de investigación cardiovascular
GRINCAR
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (13)
2024
-
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
Nefrologia, Vol. 44, Núm. 5, pp. 709-720
2023
-
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 25, Núm. 9, pp. 1571-1583
2021
-
Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival
Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21
-
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Frontiers in Cardiovascular Medicine, Vol. 8
2020
-
Expert consensus statement on heart failure with reduced ejection fraction: beyond the guidelines
Revista Espanola de Cardiologia Suplementos, Vol. 20, Núm. SB, pp. 1-46
-
Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323
-
One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
-
Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure
European Journal of Heart Failure
2019
-
Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value
Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 899-906
2018
-
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial
European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264
2017
2015
-
Adecuación en España a las recomendaciones terapéuticas de la guía de la ESC sobre insuficiencia cardiaca: ESC Heart Failure Long-term Registry
Revista Espanola de Cardiologia, Vol. 68, Núm. 9, pp. 785-793
2011
-
Validación de la versión española del Kansas City Cardiomyopathy Questionnaire
Revista Espanola de Cardiologia, Vol. 64, Núm. 1, pp. 51-58